Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences


Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the senior management team will present at the following upcoming virtual investor conferences:

  • Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Monday, September 20, 2021 at 2:55 pm ET. (access here)
  • Cantor Global Healthcare Conference on September 30, 2021 at 12:40 pm ET. (access here)

In order to participate in the audio webcasts, interested parties can also register and access presentations under "News/Events” through the “Investors” section of the Aurinia corporate website at www.auriniapharma.com. A replay of the webcasts will be available on Aurinia’s website.

ABOUT AURINIA

Aurinia is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company recently introduced the first FDA-approved oral therapy indicated for the treatment of adult patients with active lupus nephritis (LN). Aurinia’s head office is in Victoria, British Columbia; its U.S. commercial hub is in Rockville, Maryland; and the Company focuses development efforts globally.

Aurinia Pharmaceuticals Inc. Stock

€19.85
-1.620%
A loss of -1.620% shows a downward development for Aurinia Pharmaceuticals Inc..
Our community is currently high on Aurinia Pharmaceuticals Inc. with 3 Buy predictions and 0 Sell predictions.
As a result the target price of €21.00 shows a slightly positive potential of 5.793% compared to the current price of €19.85 for Aurinia Pharmaceuticals Inc..
Like: 0
Share
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Comments